project id: TCGA-LIHC; case submitter id: TCGA-G3-A7M9; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.72; rna integrity number: 8.6; age at index: 70; days to birth: -25588; days to death: 56; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1943; year of death: 2013; age at diagnosis: 25588; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: Not Reported; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 86; initial weight: 1500.0; sample id: 0ffdd482-a87e-45bc-a39b-09f5c4f23b55; sample submitter id: TCGA-G3-A7M9-01A; portion id: 20206a9b-c223-4c29-b83a-4407271a1997; portion submitter id: TCGA-G3-A7M9-01A-23; slide id: d9e42ff1-342a-4961-9962-559b87e25b71; slide submitter id: TCGA-G3-A7M9-01A-02-TSB; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 20.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; section location: TOP;